Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 284

1.

An analysis of the vascular injuries and attempted resuscitation surrounding the assassination of Martin Luther King Jr.

Long CA, Pappas TN, Southerland KW, Shortell CK.

J Vasc Surg. 2019 Nov;70(5):1652-1657. doi: 10.1016/j.jvs.2019.06.203.

PMID:
31653379
2.

Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.

Chan JA, Wetzel D, Reiling L, Miura K, Drew DR, Gilson PR, Anderson DA, Richards JS, Long CA, Suckow M, Jenzelewski V, Tsuboi T, Boyle MJ, Piontek M, Beeson JG.

PLoS One. 2019 Sep 10;14(9):e0221733. doi: 10.1371/journal.pone.0221733. eCollection 2019.

3.

Harmonization study between three laboratories for expression of malaria vaccine clinical trial IgG antibody ELISA data in µg/mL.

Labbé GM, Miura K, Silk SE, Gu W, Moon JE, Jin J, Payne RO, Fay MP, Dutta S, Long CA, Draper SJ.

Malar J. 2019 Sep 2;18(1):300. doi: 10.1186/s12936-019-2935-3.

4.

Use and 1-year outcomes with conventional and drug-coated balloon angioplasty in patients with lower extremity peripheral artery disease.

Long CA, Zepel L, Greiner MA, Hammill BG, Patel MR, Jones WS.

Am Heart J. 2019 Jul 25;217:42-51. doi: 10.1016/j.ahj.2019.07.014. [Epub ahead of print]

PMID:
31473326
5.

The Shared and Specific Genes and a Comparative Genomics Analysis within Three Hanseniaspora Strains.

Chen K, Tian Z, Jiang F, Cheng Y, Long CA.

Int J Genomics. 2019 Jun 2;2019:7910865. doi: 10.1155/2019/7910865. eCollection 2019.

6.

Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.

Alanine DGW, Quinkert D, Kumarasingha R, Mehmood S, Donnellan FR, Minkah NK, Dadonaite B, Diouf A, Galaway F, Silk SE, Jamwal A, Marshall JM, Miura K, Foquet L, Elias SC, Labbé GM, Douglas AD, Jin J, Payne RO, Illingworth JJ, Pattinson DJ, Pulido D, Williams BG, de Jongh WA, Wright GJ, Kappe SHI, Robinson CV, Long CA, Crabb BS, Gilson PR, Higgins MK, Draper SJ.

Cell. 2019 Jun 27;178(1):216-228.e21. doi: 10.1016/j.cell.2019.05.025. Epub 2019 Jun 13.

7.

Development of Penicillium italicum-Specific Primers for Rapid Detection among Fungal Isolates in Citrus.

Chen K, Tian Z, Jiang F, Long CA.

J Microbiol Biotechnol. 2019 Jun 28;29(6):984-988. doi: 10.4014/jmb.1904.04021.

8.

Strong concordance between percent inhibition in oocyst and sporozoite intensities in a Plasmodium falciparum standard membrane-feeding assay.

Miura K, Swihart BJ, Deng B, Zhou L, Pham TP, Diouf A, Fay MP, Long CA.

Parasit Vectors. 2019 May 6;12(1):206. doi: 10.1186/s13071-019-3470-3.

9.

A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates.

Douglas AD, Baldeviano GC, Jin J, Miura K, Diouf A, Zenonos ZA, Ventocilla JA, Silk SE, Marshall JM, Alanine DGW, Wang C, Edwards NJ, Leiva KP, Gomez-Puerta LA, Lucas CM, Wright GJ, Long CA, Royal JM, Draper SJ.

Nat Commun. 2019 Apr 26;10(1):1953. doi: 10.1038/s41467-019-09894-4.

10.

Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes.

Healer J, Wong W, Thompson JK, He W, Birkinshaw RW, Miura K, Long CA, Soroka V, Søgaard TMM, Jørgensen T, de Jongh WA, Weir C, Svahn E, Czabotar PE, Tham WH, Mueller I, Barlow PN, Cowman AF.

Cell Microbiol. 2019 Jul;21(7):e13030. doi: 10.1111/cmi.13030. Epub 2019 Apr 24.

11.

Plasmodium falciparum (Haemosporodia: Plasmodiidae) and O'nyong-nyong Virus Development in a Transgenic Anopheles gambiae (Diptera: Culicidae) Strain.

Mumford JD, Long CA, Weaver SC, Miura K, Wang E, Rotenberry R, Dotson EM, Benedict MQ.

J Med Entomol. 2019 Jun 27;56(4):936-941. doi: 10.1093/jme/tjz032.

12.

ELISA units, IgG subclass ratio and avidity determined functional activity of mouse anti-Pfs230 antibodies judged by a standard membrane-feeding assay with Plasmodium falciparum.

Miura K, Deng B, Wu Y, Zhou L, Pham TP, Diouf A, Wu CK, Lee SM, Plieskatt JL, Morin MJ, Long CA.

Vaccine. 2019 Apr 3;37(15):2073-2078. doi: 10.1016/j.vaccine.2019.02.071. Epub 2019 Mar 5.

13.

Identification of domains within Pfs230 that elicit transmission blocking antibody responses.

Tachibana M, Miura K, Takashima E, Morita M, Nagaoka H, Zhou L, Long CA, Richter King C, Torii M, Tsuboi T, Ishino T.

Vaccine. 2019 Mar 22;37(13):1799-1806. doi: 10.1016/j.vaccine.2019.02.021. Epub 2019 Feb 26.

14.

Combination of RTS,S and Pfs25-IMX313 Induces a Functional Antibody Response Against Malaria Infection and Transmission in Mice.

Brod F, Miura K, Taylor I, Li Y, Marini A, Salman AM, Spencer AJ, Long CA, Biswas S.

Front Immunol. 2018 Dec 4;9:2780. doi: 10.3389/fimmu.2018.02780. eCollection 2018.

15.

Complete Genome Sequences of Mycobacteriophages Kwksand96 and Cane17.

Fast KM, Keener TW, Castleberry S, Jones KD 2nd, Larrimore JD, Long CA, Newburn JT, Pritchett NC, Schellhammer PK, Sandel MW.

Microbiol Resour Announc. 2018 Nov 1;7(17). pii: e01182-18. doi: 10.1128/MRA.01182-18. eCollection 2018 Nov.

16.

Poor glycemic control is a strong predictor of postoperative morbidity and mortality in patients undergoing vascular surgery.

Long CA, Fang ZB, Hu FY, Arya S, Brewster LP, Duggan E, Duwayri Y.

J Vasc Surg. 2019 Apr;69(4):1219-1226. doi: 10.1016/j.jvs.2018.06.212. Epub 2018 Nov 17.

PMID:
30459015
17.

Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model.

Sá JM, Kaslow SR, Krause MA, Melendez-Muniz VA, Salzman RE, Kite WA, Zhang M, Moraes Barros RR, Mu J, Han PK, Mershon JP, Figan CE, Caleon RL, Rahman RS, Gibson TJ, Amaratunga C, Nishiguchi EP, Breglio KF, Engels TM, Velmurugan S, Ricklefs S, Straimer J, Gnädig NF, Deng B, Liu A, Diouf A, Miura K, Tullo GS, Eastman RT, Chakravarty S, James ER, Udenze K, Li S, Sturdevant DE, Gwadz RW, Porcella SF, Long CA, Fidock DA, Thomas ML, Fay MP, Sim BKL, Hoffman SL, Adams JH, Fairhurst RM, Su XZ, Wellems TE.

Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):12513-12518. doi: 10.1073/pnas.1813386115. Epub 2018 Nov 19.

18.

Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes.

Ito D, Takashima E, Yamasaki T, Hatano S, Hasegawa T, Miura K, Morita M, Thongkukiatkul A, Diakite M, Long CA, Sattabongkot J, Udomsangpetch R, Iriko H, Ishino T, Tsuboi T.

Parasitol Int. 2019 Feb;68(1):87-91. doi: 10.1016/j.parint.2018.10.006. Epub 2018 Oct 17.

19.

Detection of host pathways universally inhibited after Plasmodium yoelii infection for immune intervention.

Xia L, Wu J, Pattaradilokrat S, Tumas K, He X, Peng YC, Huang R, Myers TG, Long CA, Wang R, Su XZ.

Sci Rep. 2018 Oct 16;8(1):15280. doi: 10.1038/s41598-018-33599-1.

20.

Endovascular treatment of femoro-popliteal lesions.

Kansal A, Long CA, Patel MR, Jones WS.

Clin Cardiol. 2019 Jan;42(1):175-183. doi: 10.1002/clc.23098. Epub 2018 Dec 4. Review.

21.

A malaria vaccine adjuvant based on recombinant antigen binding to liposomes.

Huang WC, Deng B, Lin C, Carter KA, Geng J, Razi A, He X, Chitgupi U, Federizon J, Sun B, Long CA, Ortega J, Dutta S, King CR, Miura K, Lee SM, Lovell JF.

Nat Nanotechnol. 2018 Dec;13(12):1174-1181. doi: 10.1038/s41565-018-0271-3. Epub 2018 Oct 8.

22.

Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody.

Lennartz F, Brod F, Dabbs R, Miura K, Mekhaiel D, Marini A, Jore MM, Søgaard MM, Jørgensen T, de Jongh WA, Sauerwein RW, Long CA, Biswas S, Higgins MK.

Nat Commun. 2018 Sep 20;9(1):3822. doi: 10.1038/s41467-018-06340-9.

23.

Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults.

Chichester JA, Green BJ, Jones RM, Shoji Y, Miura K, Long CA, Lee CK, Ockenhouse CF, Morin MJ, Streatfield SJ, Yusibov V.

Vaccine. 2018 Sep 18;36(39):5865-5871. doi: 10.1016/j.vaccine.2018.08.033. Epub 2018 Aug 17.

24.

Expression of full-length Plasmodium falciparum P48/45 in P. berghei blood stages: A method to express and evaluate vaccine antigens.

Othman AS, Lin JW, Franke-Fayard BM, Kroeze H, van Pul FJA, Chevalley-Maurel S, Ramesar J, Marin-Mogollon C, Jore MM, Morin MJ, Long CA, Sauerwein R, Birkett A, Miura K, Janse CJ, Khan SM.

Mol Biochem Parasitol. 2018 Sep;224:44-49. doi: 10.1016/j.molbiopara.2018.07.009. Epub 2018 Jul 24.

25.

Malaria Vaccines: Recent Advances and New Horizons.

Draper SJ, Sack BK, King CR, Nielsen CM, Rayner JC, Higgins MK, Long CA, Seder RA.

Cell Host Microbe. 2018 Jul 11;24(1):43-56. doi: 10.1016/j.chom.2018.06.008. Review.

26.

Antagonistic Activity and the Mechanism of Bacillus amyloliquefaciens DH-4 Against Citrus Green Mold.

Chen K, Tian Z, Luo Y, Cheng Y, Long CA.

Phytopathology. 2018 Nov;108(11):1253-1262. doi: 10.1094/PHYTO-01-17-0032-R. Epub 2018 Oct 2.

PMID:
29799309
27.

TLR-adjuvanted nanoparticle vaccines differentially influence the quality and longevity of responses to malaria antigen Pfs25.

Thompson EA, Ols S, Miura K, Rausch K, Narum DL, Spångberg M, Juraska M, Wille-Reece U, Weiner A, Howard RF, Long CA, Duffy PE, Johnston L, O'Neil CP, Loré K.

JCI Insight. 2018 May 17;3(10). pii: 120692. doi: 10.1172/jci.insight.120692. eCollection 2018 May 17.

28.

Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines.

Menon V, Kapulu MC, Taylor I, Jewell K, Li Y, Hill F, Long CA, Miura K, Biswas S.

Front Immunol. 2018 Jan 19;8:1998. doi: 10.3389/fimmu.2017.01998. eCollection 2017.

29.

Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission.

Kapoor N, Vanjak I, Rozzelle J, Berges A, Chan W, Yin G, Tran C, Sato AK, Steiner AR, Pham TP, Birkett AJ, Long CA, Fairman J, Miura K.

Biochemistry. 2018 Feb 6;57(5):516-519. doi: 10.1021/acs.biochem.7b01099. Epub 2018 Jan 16.

30.

Host age and Plasmodium falciparum multiclonality are associated with gametocyte prevalence: a 1-year prospective cohort study.

Adomako-Ankomah Y, Chenoweth MS, Tocker AM, Doumbia S, Konate D, Doumbouya M, Keita AS, Anderson JM, Fairhurst RM, Diakite M, Miura K, Long CA.

Malar J. 2017 Nov 21;16(1):473. doi: 10.1186/s12936-017-2123-2.

31.

Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.

Payne RO, Silk SE, Elias SC, Miura K, Diouf A, Galaway F, de Graaf H, Brendish NJ, Poulton ID, Griffiths OJ, Edwards NJ, Jin J, Labbé GM, Alanine DG, Siani L, Di Marco S, Roberts R, Green N, Berrie E, Ishizuka AS, Nielsen CM, Bardelli M, Partey FD, Ofori MF, Barfod L, Wambua J, Murungi LM, Osier FH, Biswas S, McCarthy JS, Minassian AM, Ashfield R, Viebig NK, Nugent FL, Douglas AD, Vekemans J, Wright GJ, Faust SN, Hill AV, Long CA, Lawrie AM, Draper SJ.

JCI Insight. 2017 Nov 2;2(21). pii: 96381. doi: 10.1172/jci.insight.96381.

32.

Functional characterization and comparison of Plasmodium falciparum proteins as targets of transmission-blocking antibodies.

Nikolaeva D, Illingworth JJ, Miura K, Alanine DG, Brian IJ, Li Y, Fyfe AJ, Da DF, Cohuet A, Long CA, Draper SJ, Biswas S.

Mol Cell Proteomics. 2017 Oct 31. pii: mcp.RA117.000036. doi: 10.1074/mcp.RA117.000036. [Epub ahead of print]

33.

Comparative assessment of An. gambiae and An. stephensi mosquitoes to determine transmission-reducing activity of antibodies against P. falciparum sexual stage antigens.

Eldering M, Bompard A, Miura K, Stone W, Morlais I, Cohuet A, van Gemert GJ, Brock PM, Rijpma SR, van de Vegte-Bolmer M, Graumans W, Siebelink-Stoter R, Da DF, Long CA, Morin MJ, Sauerwein RW, Churcher TS, Bousema T.

Parasit Vectors. 2017 Oct 17;10(1):489. doi: 10.1186/s13071-017-2414-z.

34.

Evaluation of a Plasmodium-Specific Carrier Protein To Enhance Production of Recombinant Pfs25, a Leading Transmission-Blocking Vaccine Candidate.

Parzych EM, Miura K, Ramanathan A, Long CA, Burns JM Jr.

Infect Immun. 2017 Dec 19;86(1). pii: e00486-17. doi: 10.1128/IAI.00486-17. Print 2018 Jan.

35.

Mechanism of splenic cell death and host mortality in a Plasmodium yoelii malaria model.

Lacerda-Queiroz N, Riteau N, Eastman RT, Bock KW, Orandle MS, Moore IN, Sher A, Long CA, Jankovic D, Su XZ.

Sci Rep. 2017 Sep 5;7(1):10438. doi: 10.1038/s41598-017-10776-2.

36.

High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization.

Arya S, Binney ZO, Khakharia A, Long CA, Brewster LP, Wilson PW, Jordan WD Jr, Duwayri Y.

J Vasc Surg. 2018 Jan;67(1):217-228.e1. doi: 10.1016/j.jvs.2017.06.101. Epub 2017 Aug 31.

37.

A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection.

Srinivasan P, Baldeviano GC, Miura K, Diouf A, Ventocilla JA, Leiva KP, Lugo-Roman L, Lucas C, Orr-Gonzalez S, Zhu D, Villasante E, Soisson L, Narum DL, Pierce SK, Long CA, Diggs C, Duffy PE, Lescano AG, Miller LH.

NPJ Vaccines. 2017;2. pii: 14. doi: 10.1038/s41541-017-0015-7. Epub 2017 May 22.

38.

A Plasmodium yoelii HECT-like E3 ubiquitin ligase regulates parasite growth and virulence.

Nair SC, Xu R, Pattaradilokrat S, Wu J, Qi Y, Zilversmit M, Ganesan S, Nagarajan V, Eastman RT, Orandle MS, Tan JC, Myers TG, Liu S, Long CA, Li J, Su XZ.

Nat Commun. 2017 Aug 9;8(1):223. doi: 10.1038/s41467-017-00267-3.

39.

Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines.

Leneghan DB, Miura K, Taylor IJ, Li Y, Jin J, Brune KD, Bachmann MF, Howarth M, Long CA, Biswas S.

Sci Rep. 2017 Jun 19;7(1):3811. doi: 10.1038/s41598-017-03798-3.

40.

Functional Analysis Reveals Geographical Variation in Inhibitory Immune Responses Against a Polymorphic Malaria Antigen.

Bei AK, Ahouidi AD, Dvorin JD, Miura K, Diouf A, Ndiaye D, Premji Z, Diakite M, Mboup S, Long CA, Duraisingh MT.

J Infect Dis. 2017 Jul 15;216(2):267-275. doi: 10.1093/infdis/jix280.

41.

The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens.

Diemen PMV, Leneghan DB, Brian IJ, Miura K, Long CA, Milicic A, Biswas S, Rollier CS, Wyllie DH.

Sci Rep. 2017 May 11;7(1):1745. doi: 10.1038/s41598-017-01421-z.

42.

Immune Responses in Malaria.

Long CA, Zavala F.

Cold Spring Harb Perspect Med. 2017 Aug 1;7(8). pii: a025577. doi: 10.1101/cshperspect.a025577. Review.

43.

Immunoscreening of Plasmodium falciparum proteins expressed in a wheat germ cell-free system reveals a novel malaria vaccine candidate.

Morita M, Takashima E, Ito D, Miura K, Thongkukiatkul A, Diouf A, Fairhurst RM, Diakite M, Long CA, Torii M, Tsuboi T.

Sci Rep. 2017 Apr 5;7:46086. doi: 10.1038/srep46086.

44.

High Plasmodium falciparum longitudinal prevalence is associated with high multiclonality and reduced clinical malaria risk in a seasonal transmission area of Mali.

Adomako-Ankomah Y, Chenoweth MS, Durfee K, Doumbia S, Konate D, Doumbouya M, Keita AS, Nikolaeva D, Tullo GS, Anderson JM, Fairhurst RM, Daniels R, Volkman SK, Diakite M, Miura K, Long CA.

PLoS One. 2017 Feb 3;12(2):e0170948. doi: 10.1371/journal.pone.0170948. eCollection 2017.

45.

Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria Infection.

Hodgson SH, Llewellyn D, Silk SE, Milne KH, Elias SC, Miura K, Kamuyu G, Juma EA, Magiri C, Muia A, Jin J, Spencer AJ, Longley RJ, Mercier T, Decosterd L, Long CA, Osier FH, Hoffman SL, Ogutu B, Hill AV, Marsh K, Draper SJ.

Front Microbiol. 2016 Oct 13;7:1604. eCollection 2016.

46.

Increased CD40 Expression Enhances Early STING-Mediated Type I Interferon Response and Host Survival in a Rodent Malaria Model.

Yao X, Wu J, Lin M, Sun W, He X, Gowda C, Bolland S, Long CA, Wang R, Su XZ.

PLoS Pathog. 2016 Oct 7;12(10):e1005930. doi: 10.1371/journal.ppat.1005930. eCollection 2016 Oct.

47.

An endovascular model of ischemic myopathy from peripheral arterial disease.

Long CA, Timmins LH, Koutakis P, Goodchild TT, Lefer DJ, Pipinos II, Casale GP, Brewster LP.

J Vasc Surg. 2017 Sep;66(3):891-901. doi: 10.1016/j.jvs.2016.07.127. Epub 2016 Sep 29.

48.

An inter-laboratory comparison of standard membrane-feeding assays for evaluation of malaria transmission-blocking vaccines.

Miura K, Stone WJ, Koolen KM, Deng B, Zhou L, van Gemert GJ, Locke E, Morin M, Bousema T, Sauerwein RW, Long CA, Dechering KJ.

Malar J. 2016 Sep 9;15:463. doi: 10.1186/s12936-016-1515-z.

49.

Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay.

Miura K, Swihart BJ, Deng B, Zhou L, Pham TP, Diouf A, Burton T, Fay MP, Long CA.

Vaccine. 2016 Jul 29;34(35):4145-4151. doi: 10.1016/j.vaccine.2016.06.066. Epub 2016 Jun 29.

50.

Hematological Indices in Malian Children Change Significantly During a Malaria Season and with Increasing Age: Implications for Malaria Epidemiological Studies.

Diakite M, Miura K, Diouf A, Konate D, Keita AS, Doumbia S, Diakite S, Traore K, Doumbouya M, Anderson JM, Fairhurst RM, Long CA.

Am J Trop Med Hyg. 2016 Aug 3;95(2):368-72. doi: 10.4269/ajtmh.16-0125. Epub 2016 Jun 13.

Supplemental Content

Support Center